Abstract
Background: To assess the efficacy and safety of corticosteroids in COVID-19 patients compared with standard care or placebo.
Methods: Electronic databases were searched to identify relevant studies. The mortality, adverse events, and other data from studies were pooled for statistical analysis.
Results: Ten randomized clinical trials were eligible for inclusion. Corticosteroid treatment in COVID-19 patients did not significantly reduce the risk of death (RR: 0.93; CI: 0.82, 1.05) and the need for mechanical ventilation (RR: 0.82; CI: 0.62, 1.08). No mortality reduction was also observed in the subgroup of patients requiring mechanical ventilation (RR: 0.90; CI: 0.79-1.03). The use of corticosteroids increased mortality in the subgroup of patients not requiring oxygen support (RR: 1.24; CI: 1.00-1.55). The survival benefit was observed in a low dosage of corticosteroids (RR: 0.90; CI: 0.84-0.97) and dexamethasone (RR: 0.90; 95% CI: 0.79-1.04). There was no difference in the rates of adverse events (RR: 1.13; CI: 0.58, 2.20) and secondary infections (RR: 0.87; CI: 0.66, 1.15).
Conclusion: Corticosteroid treatment did not convincingly improve survival in severe COVID-19 patients. Low-dose dexamethasone could be considered as a drug for the treatment of COVID-19 patients. More high-quality trials are needed to further verify this conclusion. Expert Opinion : The effect of corticosteroids on patient survival highly depended on the selection of the right dosage and type and in a specific subgroup of patients. This meta-analysis, which included more RCTs, evaluated the safety and efficacy in severe COVID-19 patients and analyzed the effects of different types of corticosteroid treatments. Corticosteroid treatment did not convincingly improve survival in severe COVID-19 patients. But the low dose dexamethasone appear to have a role in the management of severe COVID-19 patients.
Keywords: COVID-19; adverse events; corticosteroids; dose; mortality.
【저자키워드】 COVID-19, Corticosteroids, Mortality, adverse events, dose, 【초록키워드】 Corticosteroid, Dexamethasone, Treatment, Meta-analysis, randomized clinical trial, Efficacy, Corticosteroids, Mortality, Trial, mechanical ventilation, clinical trials, oxygen, drug, database, adverse events, survival, Secondary infection, management, adverse event, Efficacy and safety, Placebo, secondary infections, COVID-19 patients, RCTs, statistical analysis, COVID-19 patient, reduction, risk of death, patient survival, standard care, dosage, no difference, severe COVID-19 patients, opinion, increased mortality, treatment of COVID-19 patients, oxygen support, corticosteroid treatment, Effect, expert, benefit, low dose dexamethasone, corticosteroid treatments, IMPROVE, analyzed, identify, significantly, evaluated, searched, reduce, eligible, for inclusion, severe COVID-19 patient, subgroup of patient, subgroup of patients, use of corticosteroid, 【제목키워드】 Randomized controlled trial, Meta-analysis, severe COVID-19, corticosteroid therapy, Effect,